The largest trial to examine the impact of colchicine in acute myocardial infarction (MI) found that both acute and long-term ...

The Independent Data Monitoring Committee met this week on February 10, 2025 to evaluate the unblinded safety Phase 2b QUALITY data and recommended to continue the QUALITY extension study as designed- ...

Although the use of i.v. colchicine at UPMC has been minimal, safety guidelines were developed because of the severity of some adverse events. The low therapeutic index, particularly in patients ...

For those living with joint pain, there’s some good news. A recent study suggests that a pill called colchicine might help reduce the chances of needing knee or hip replacement surgeries. Let’s take a ...

Colchicine use was associated with 47% less likelihood of postvaccine gout flare. Conclusion COVID-19 vaccination was associated with increased odds of gout flare, which developed mainly in month 1 ...

Colchicine, a cheap and readily available anti-inflammatory drug used to treat diseases such as gout, is to be investigated as a potential therapy for COVID-19 in the UK’s ground-breaking ...

Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary endpoint of preservation of lean mass as well as greater ...

Inc. reported its Q1 FY2025 earnings, revealing a net loss per share of $0.06, which was better than the projected loss of $0.08. The company's revenue reached $3.2 million, surpassing the forecast of ...

We are at a critical time and supporting climate journalism is more important than ever. Science News and our parent organization, the Society for Science, need your help to strengthen ...

11 These potential adverse effects should be discussed with patients along with the potential benefits of colchicine use so that they can make a well-informed decision. This study is a very important ...